METTL3 and cancer: According to the results of cell phenotype assays, the JAK1-STAT3 signaling downstream effectors, including VEGFA and CCND1, were screened out and their functions were uncovered in cancer cells, but themselves were also reported as METTL3-modified targets in a recent study [30].